faranoxi

Also Known As:

p-(di(2-chloroethyl)amino)phenylacetic acid, N-oxide, phosphate salt

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

1.	Melanoma (Melanoma, Malignant) 02/01/1996 - "It should be noted that primary melanoma was less responsive to faranoxi compared to lymphoid metastases. " 02/01/1996 - "Clinical studies demonstrate the antitumor activity of faranoxi against melanoma, lymphoma and rectal cancer. " 02/01/1996 - "Using the combination regimen FDV (faranoxi, deticene, vincristine) as treatment of melanoma, partial remission was achieved in up to 50% of the cases. "
2.	Rectal Neoplasms (Rectal Cancer) 02/01/1996 - "Clinical studies demonstrate the antitumor activity of faranoxi against melanoma, lymphoma and rectal cancer. "
3.	Lymphoma (Lymphomas) 02/01/1996 - "Clinical studies demonstrate the antitumor activity of faranoxi against melanoma, lymphoma and rectal cancer. "
4.	Neoplasm Metastasis (Metastasis) 02/01/1996 - "It should be noted that primary melanoma was less responsive to faranoxi compared to lymphoid metastases. "